Vanquis Banking Group plc (LON:VANQ)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	286	113	328	480	901	770
Market Cap Growth	101.47%	-65.41%	-31.74%	-46.74%	17.04%	-32.70%
PE Ratio	-	-	-	6.20	-	-
PS Ratio	1.03	0.42	1.01	1.15	2.09	3.17
PB Ratio	0.66	0.26	0.58	0.78	1.43	1.19
P/FCF Ratio	1.35	0.26	0.56	-	5.57	2.15
P/OCF Ratio	1.36	0.26	0.56	-	5.52	2.12
Debt / Equity Ratio	6.78	6.51	4.53	3.22	3.05	3.51
Debt / FCF Ratio	13.93	6.56	4.43	-	11.88	6.35
Quick Ratio	50.16	2.10	1.93	2.29	4.69	34.69
Current Ratio	50.16	2.12	1.95	2.31	4.73	34.95
Asset Turnover	0.08	0.08	0.11	0.16	0.15	0.08
Return on Equity (ROE)	-16.36%	-23.62%	-1.98%	13.21%	21.05%	-5.37%
Return on Assets (ROA)	-2.42%	-3.63%	-0.40%	3.06%	4.64%	-1.24%
Earnings Yield	-27.23%	-105.29%	-3.57%	16.13%	-3.56%	-10.83%
Earnings Yield	-27.23%	-105.29%	-3.57%	16.13%	-3.56%	-10.83%
FCF Yield	73.96%	386.57%	177.49%	-43.45%	17.96%	46.50%
Dividend Yield	-	-	4.74%	8.92%	4.00%	-
Payout Ratio	-	-	-	55.30%	-	-
Buyback Yield / Dilution	-0.22%	-0.99%	0.28%	-0.68%	0.63%	0.67%
Total Shareholder Return	-	-0.99%	5.02%	8.24%	4.63%	0.67%

Source: S&P Global Market Intelligence. Financial Services template. Financial Sources.